Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting

World Health Organization. Diabetes facts. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.html. Accessed December 13, 2007.

World Health Organization. Diabetes action now booklet: a life-threatening condition. Available at: www.who.int/diabetes/BOOKLET_HTML/en/index3.html. Accessed December 13, 2007.

Hogan, 2003, Economic costs of diabetes in the US in 2002, Diabetes Care, 26, 917, 10.2337/diacare.26.3.917

1991, VIII, Diabetologia, 34, 877

Deshpande, 2008, Epidemiology of diabetes and diabetes-related complications, Phys Ther, 88, 1254, 10.2522/ptj.20080020

Rahman, 2007, Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis, Diabetes Obes Metab, 9, 767, 10.1111/j.1463-1326.2006.00655.x

Davey Smith, 2005, Incidence of type 2 diabetes in the Randomized Multiple Risk Factor Intervention Trial, Ann Intern Med, 142, 313, 10.7326/0003-4819-142-5-200503010-00006

Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801

Eriksson, 1989, Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus, N Engl J Med, 321, 337, 10.1056/NEJM198908103210601

Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512

Harding, 2003, Extracts from “concise clinical evidence”: diabetic retinopathy, BMJ, 326, 1023, 10.1136/bmj.326.7397.1023

Sheetz, 2002, Molecular understanding of hyperglycemia's adverse effects for diabetic complications, JAMA, 288, 2579, 10.1001/jama.288.20.2579

Orchard, 1990, Prevalence of complications in IDDM by sex and duration, Diabetes, 39, 1116, 10.2337/diab.39.9.1116

Kempen, 2004, The prevalence of diabetic retinopathy among adults in the United States, Arch Ophthalmol, 122, 552, 10.1001/archopht.122.4.552

Klein, 1984, The Wisconsin epidemiologic study of diabetic retinopathy, Arch Ophthalmol, 102, 520, 10.1001/archopht.1984.01040030398010

Klein, 1984, The Wisconsin epidemiologic study of diabetic retinopathy, Arch Ophthalmol, 102, 527, 10.1001/archopht.1984.01040030405011

Tyrberg, 2007, Retinopathy in subjects with impaired fasting glucose: the NANSY-Eye baseline report, Diabetes Obes Metab

Brazionis, 2008, Homocysteine and diabetic retinopathy, Diabetes Care, 31, 50, 10.2337/dc07-0632

Romero, 2007, Renal and retinal microangiopathy after 15 years of follow-up study in a sample of type 1 diabetes mellitus patients, Journal of Diabetes Complications, 21, 93, 10.1016/j.jdiacomp.2006.04.001

Cundiff, 2005, Diet and diabetic retinopathy: insights from the Diabetes Control and Complications Trial (DCCT), MedGenMed, 7, 3

Cusick, 2003, Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels, Ophthalmology, 110, 2126, 10.1016/j.ophtha.2003.01.001

Wilkinson-Berka, 2004, Diabetes and retinal vascular disorders: role of the renin-angiotensin system, Expert Rev Mol Med, 6, 1, 10.1017/S1462399404008129

Yamagishi, 2005, Pericyte biology and diseases, Int J Tissue React, 27, 125

Rajala, 2000, High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy, Diabetes Care, 23, 957, 10.2337/diacare.23.7.957

Yamagishi, 1993, Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells, Biochem Biophys Res Commun, 190, 418, 10.1006/bbrc.1993.1064

Carlson, 2003, Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice, Anat Rec A Discov Mol Cell Evol Biol, 271, 332, 10.1002/ar.a.10038

Hammes, 2005, Pericytes and the pathogenesis of diabetic retinopathy, Horm Metab Res, 37, 39, 10.1055/s-2005-861361

Henricsson, 1997, The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus, Diabet Med, 14, 123, 10.1002/(SICI)1096-9136(199702)14:2<123::AID-DIA306>3.0.CO;2-U

1998, UK Prospective Diabetes Study (UKPDS) Group, Lancet, 352, 837

Kohner, 1995, Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy, Diabetes, 44, 603, 10.2337/diab.44.6.603

Dyck, 1993, The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study, Neurology, 43, 817, 10.1212/WNL.43.4.817

Vinik, 2003, Diabetic autonomic neuropathy, Diabetes Care, 26, 1553, 10.2337/diacare.26.5.1553

Boulton, 1997, Foot problems in patients with diabetes mellitus, Textbook of Diabetes, 1

Sumner, 2003, The spectrum of neuropathy in diabetes and impaired glucose tolerance, Neurology, 60, 108, 10.1212/WNL.60.1.108

Dyck, 1999, Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort, Diabetes Care, 22, 1479, 10.2337/diacare.22.9.1479

Tesfaye, 1996, Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study, Diabetologia, 39, 1377, 10.1007/s001250050586

Thrainsdottir, 2003, Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man, Diabetes, 52, 2615, 10.2337/diabetes.52.10.2615

Yang, 2001, Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy, Brain, 124, 1149, 10.1093/brain/124.6.1149

Malik, 1989, Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy, Diabetologia, 32, 92, 10.1007/BF00505180

Mueller, 2008, Plantar stresses on the neuropathic foot during barefoot walking, Phys Ther, 88, 1375, 10.2522/ptj.20080011

LeMaster, 2008, Effect of weight-bearing activity on foot ulcer incidence in people with diabetic peripheral neuropathy: Feet First randomized controlled trial, Phys Ther, 88, 1385, 10.2522/ptj.20080019

Hilton, 2008, Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function, Phys Ther, 88, 1336, 10.2522/ptj.20080079

Dyck, 1996, Pathologic alterations in the diabetic neuropathies of humans: a review, J Neuropathol Exp Neurol, 55, 1181, 10.1097/00005072-199612000-00001

Ibrahim, 1999, A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy, Diabetologia, 42, 737, 10.1007/s001250051222

Young, 1992, Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy, Diabetologia, 35, 1146, 10.1007/BF00401368

Malik, 1993, Endoneurial localisation of microvascular damage in human diabetic neuropathy, Diabetologia, 36, 454, 10.1007/BF00402283

Yagihashi, 1992, Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats, Diabetes, 41, 47, 10.2337/diab.41.1.47

Cotter, 2002, Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozocin-induced diabetes, Clin Sci (Lond), 103, 311, 10.1042/cs1030311

Nakamura, 1999, A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozocin-induced diabetic rats, Diabetes, 48, 2090, 10.2337/diabetes.48.10.2090

Vlassara, 1984, Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation end products, J Exp Med, 160, 197, 10.1084/jem.160.1.197

Vinik, 2007, Diabetic cardiovascular autonomic neuropathy, Circulation, 115, 387, 10.1161/CIRCULATIONAHA.106.634949

Cheng, 2003, Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes, Diabetes Care, 26, 2052, 10.2337/diacare.26.7.2052

Witte, 2005, Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus, Diabetologia, 48, 164, 10.1007/s00125-004-1617-y

Drummond, 2002, The early natural history of nephropathy in type 1 diabetes, II: early renal structural changes in type 1 diabetes, Diabetes, 51, 1580, 10.2337/diabetes.51.5.1580

Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl J Med, 345, 861, 10.1056/NEJMoa011161

Adler, 2003, Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64), Kidney Int, 63, 225, 10.1046/j.1523-1755.2003.00712.x

Friedman, 1990, Diabetic renal disease, Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice, 684

Chen, 2001, The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy, Ren Fail, 23, 471, 10.1081/JDI-100104730

van Dijk, 2004, Pathogenesis of diabetic nephropathy, Rev Endocr Metab Disord, 5, 237, 10.1023/B:REMD.0000032412.91984.ec

Hasslacher, 1989, Similar risks of nephropathy in patients with type I or type II diabetes mellitus, Nephrol Dial Transplant, 4, 859, 10.1093/ndt/4.10.859

Linseman, 1995, Lung tumor induction in A/J mice and clastogenic effects in CD-1 mice of the sequence-selective DNA alkylating agents (+)-CC-1065 and (−)-CC-1065, Nat Toxins, 3, 32, 10.1002/nt.2620030108

Kramer, 2005, Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program, Am J Kidney Dis, 46, 587, 10.1053/j.ajkd.2005.06.007

Laakso, 1999, Hyperglycemia and cardiovascular disease in type 2 diabetes, Diabetes, 48, 937, 10.2337/diabetes.48.5.937

American Heart Association. The heart of diabetes. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3044762. Accessed December 3, 2007.

Buyken, 2007, Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM Study, Eur J Cardiovasc Prev Rehabil, 14, 230, 10.1097/HJR.0b013e3280142037

Bonora, 2002, HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study, Diabetes Care, 25, 1135, 10.2337/diacare.25.7.1135

Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N Engl J Med, 339, 229, 10.1056/NEJM199807233390404

Malmberg, 2000, Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry, Circulation, 102, 1014, 10.1161/01.CIR.102.9.1014

Facchini, 2001, Insulin resistance as a predictor of age-related diseases, J Clin Endocrinol Metab, 86, 3574, 10.1210/jcem.86.8.7763

Mufunda, 2006, Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa, Ethn Dis, 16, 521

Turner, 1996, United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus, Ann Intern Med, 124, 136, 10.7326/0003-4819-124-1_Part_2-199601011-00011

Reusch, 2007, Atherosclerosis in diabetes and insulin resistance, Diabetes Obes Metab, 9, 455, 10.1111/j.1463-1326.2006.00620.x

2001, JAMA, 285, 2486, 10.1001/jama.285.19.2486

Beckman, 2002, Diabetes and atherosclerosis: epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570

Centers for Disease Control and Prevention. Stroke. Available at: http://www.cdc.gov/stroke/. Accessed January 5, 2008.

Abbott, 2003, Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke, J Clin Epidemiol, 56, 479, 10.1016/S0895-4356(02)00611-X

Ohira, 2006, Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities Study, Stroke, 37, 2493, 10.1161/01.STR.0000239694.19359.88

Folsom, 1999, Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study Investigators, Diabetes Care, 22, 1077, 10.2337/diacare.22.7.1077

Rohr, 1996, Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study, Arch Neurol, 53, 603, 10.1001/archneur.1996.00550070041010

Tuomilehto, 1996, Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population, Stroke, 27, 210, 10.1161/01.STR.27.2.210

Haheim, 1995, Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects: 18-year follow-up of the Oslo Study, Stroke, 26, 774, 10.1161/01.STR.26.5.774

Ribo, 2005, Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients, Stroke, 36, 1705, 10.1161/01.STR.0000173161.05453.90.9f

Parsons, 2002, Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study, Ann Neurol, 52, 20, 10.1002/ana.10241

Megherbi, 2003, Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project, Stroke, 34, 688, 10.1161/01.STR.0000057975.15221.40

Sprafka, 1994, Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: the Minnesota Heart Survey, Diabet Med, 11, 678, 10.1111/j.1464-5491.1994.tb00332.x

Elneihoum, 1998, Three-year survival and recurrence after stroke in Malmo, Sweden: an analysis of stroke registry data, Stroke, 29, 2114, 10.1161/01.STR.29.10.2114

Fabris, 1994, Carotid plaque, aging, and risk factors: a study of 457 subjects, Stroke, 25, 1133, 10.1161/01.STR.25.6.1133

Friedlander, 2000, The prevalence of calcified carotid artery atheromas on the panoramic radiographs of patients with type 2 diabetes mellitus, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 89, 420, 10.1016/S1079-2104(00)70122-3

Stegmayr, 1995, Diabetes as a risk factor for stroke: a population perspective, Diabetologia, 38, 1061, 10.1007/BF00402176

Niskanen, 1998, Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis, Diabetes Care, 21, 1861, 10.2337/diacare.21.11.1861

Sasaki, 1995, Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan, Diabetes Res Clin Pract, 27, 77, 10.1016/0168-8227(94)01018-U

Shinozaki, 1996, Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke, Stroke, 27, 37, 10.1161/01.STR.27.1.37

Zunker, 1996, Hyperinsulinism and cerebral microangiopathy, Stroke, 27, 219, 10.1161/01.STR.27.2.219

Davis, 1999, Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29, Arch Intern Med, 159, 1097, 10.1001/archinte.159.10.1097

Guerrero-Romero, 1999, Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus, Stroke, 30, 1787, 10.1161/01.STR.30.9.1787

Lehto, 1998, Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus, Stroke, 29, 635, 10.1161/01.STR.29.3.635

Engstrom, 2003, Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study, Diabetes, 52, 442, 10.2337/diabetes.52.2.442

2003, Peripheral arterial disease in people with diabetes, Diabetes Care, 26, 3333, 10.2337/diacare.26.12.3333

Kullo, 2003, Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) Study, Vasc Med, 8, 237, 10.1191/1358863x03vm511oa

Schainfeld, 2001, Management of peripheral arterial disease and intermittent claudication, J Am Board Fam Pract, 14, 443

Vogt, 1994, Functional status and mobility among elderly women with lower extremity arterial disease: the Study of Osteoporotic Fractures, J Am Geriatr Soc, 42, 923, 10.1111/j.1532-5415.1994.tb06581.x

McDermott, 2004, Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms, JAMA, 292, 453, 10.1001/jama.292.4.453

Adler, 1999, Lower-extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers, Diabetes Care, 22, 1029, 10.2337/diacare.22.7.1029

Dickinson, 2002, Neurovascular disease, antioxidants and glycation in diabetes, Diabetes Metab Res Rev, 18, 260, 10.1002/dmrr.305

Forsblom, 1998, Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4, Diabetologia, 41, 1253, 10.1007/s001250051062

Jude, 2001, Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome, Diabetes Care, 24, 1433, 10.2337/diacare.24.8.1433

Al-Delaimy, 2004, Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men, Am J Med, 116, 236, 10.1016/j.amjmed.2003.09.038

Selvin, 2004, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus, Ann Intern Med, 141, 421, 10.7326/0003-4819-141-6-200409210-00007

American Heart Association. Peripheral arterial disease risk factors and possible complications. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3020256. Accessed January 5, 2008.

Wattanakit, 2005, Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study, Atherosclerosis, 180, 389, 10.1016/j.atherosclerosis.2004.11.024

Brownlee, 1988, Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications, N Engl J Med, 318, 1315, 10.1056/NEJM198805193182007

Stitt, 2002, Advanced glycation end products and diabetic complications, Expert Opin Investig Drugs, 11, 1205, 10.1517/13543784.11.9.1205

Giardino, 1994, Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes, J Clin Invest, 94, 110, 10.1172/JCI117296

Yamagishi, 1995, Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy, Biochem Biophys Res Commun, 213, 681, 10.1006/bbrc.1995.2185

Campochiaro, 2000, Retinal and choroidal neovascularization, J Cell Physiol, 184, 301, 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H

Yamagishi, 2002, Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes, Biochem Biophys Res Commun, 290, 973, 10.1006/bbrc.2001.6312

Benjamin, 1998, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF, Development, 125, 1591, 10.1242/dev.125.9.1591

Chibber, 2007, Leukocytes in diabetic retinopathy, Curr Diabetes Rev, 3, 3, 10.2174/157339907779802139

Boeri, 2001, Increased prevalence of microthromboses in retinal capillaries of diabetic individuals, Diabetes, 50, 1432, 10.2337/diabetes.50.6.1432

Schmidt, 2000, RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes, Trends Endocrinol Metab, 11, 368, 10.1016/S1043-2760(00)00311-8

Silbiger, 1993, Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge, Kidney Int, 43, 853, 10.1038/ki.1993.120

Matsumura, 2000, Advanced glycation end products and the pathogenesis of diabetic complications, Diabetes Mellitus: A Fundamental and Clinical Text, 983

Osterby, 1988, A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy, Diabetologia, 31, 265, 10.1007/BF00277406

Spranger, 2001, Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease, Diabetes, 50, 2641, 10.2337/diabetes.50.12.2641

Kinoshita, 1988, The involvement of aldose reductase in diabetic complications, Diabetes Metab Rev, 4, 323, 10.1002/dmr.5610040403

Sima, 2003, New insights into the metabolic and molecular basis for diabetic neuropathy, Cell Mol Life Sci, 60, 2445, 10.1007/s00018-003-3084-x

Vincent, 2004, New insights into the mechanisms of diabetic neuropathy, Rev Endocr Metab Disord, 5, 227, 10.1023/B:REMD.0000032411.11422.e0

Gilbert, 2003, The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations, Diabet Med, 20, 607, 10.1046/j.1464-5491.2003.00979.x

Yamagishi, 2005, Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy, Curr Pharm Des, 11, 2279, 10.2174/1381612054367300

Girach, 2006, Diabetic microvascular complications: can patients at risk be identified, Int J Clin Pract, 60, 1471, 10.1111/j.1742-1241.2006.01175.x

Williams, 1996, Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus, J Am Coll Cardiol, 27, 567, 10.1016/0735-1097(95)00522-6

De Vriese, 2000, Endothelial dysfunction in diabetes, Br J Pharmacol, 130, 963, 10.1038/sj.bjp.0703393

Milstien, 1999, Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function, Biochem Biophys Res Commun, 263, 681, 10.1006/bbrc.1999.1422

Grant, 2007, Diabetes mellitus as a prothrombotic condition, J Intern Med, 262, 157, 10.1111/j.1365-2796.2007.01824.x

Hennes, 1996, Insulin-resistant lipolysis in abdominally obese hypertensive individuals: role of the renin-angiotensin system, Hypertension, 28, 120, 10.1161/01.HYP.28.1.120

Inoguchi, 2000, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells, Diabetes, 49, 1939, 10.2337/diabetes.49.11.1939

Linden, 2008, Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation, Clin J Am Soc Nephrol, 3, 691, 10.2215/CJN.04291007

Rask-Madsen, 2007, Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes, Nat Clin Pract Endocrinol Metab, 3, 46, 10.1038/ncpendmet0366

Assert, 2001, Regulation of protein kinase C by short- term hyperglycaemia in human platelets in vivo and in vitro, Diabetologia, 44, 188, 10.1007/s001250051598

Carr, 2001, Diabetes mellitus: a hypercoagulable state, Journal of Diabetes Complications, 15, 44, 10.1016/S1056-8727(00)00132-X

Hansson, 2006, Inflammation and atherosclerosis, Annu Rev Pathol, 1, 297, 10.1146/annurev.pathol.1.110304.100100

Williams, 2007, Inflammatory mechanisms of diabetic complications, Curr Diab Rep, 7, 242, 10.1007/s11892-007-0038-y

Suzuki, 2001, Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels, Diabetes, 50, 851, 10.2337/diabetes.50.4.851

Mankovsky, 2004, Stroke in patients with diabetes mellitus, Diabetes Metab Res Rev, 20, 268, 10.1002/dmrr.490

Hoxworth, 1999, Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation, Brain Res, 821, 467, 10.1016/S0006-8993(98)01332-8

Siesjo, 1995, Glutamate, calcium, and free radicals as mediators of ischemic brain damage, Ann Thorac Surg, 59, 1316, 10.1016/0003-4975(95)00077-X

Li, 2000, Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia, Stroke, 31, 183, 10.1161/01.STR.31.1.183

Giannini, 2007, Role of physical exercise in children and adolescents with diabetes mellitus, J Pediatr Endocrinol Metab, 20, 173, 10.1515/JPEM.2007.20.2.173

O'Gorman, 2006, Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes, Diabetologia, 49, 2983, 10.1007/s00125-006-0457-3

Sato, 2007, Clinical aspects of physical exercise for diabetes/metabolic syndrome, Diabetes Res Clin Pract, 77, S87, 10.1016/j.diabres.2007.01.039

Ivy, 1997, Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus, Sports Med, 24, 321, 10.2165/00007256-199724050-00004

Bruce, 2005, Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: the Fremantle Diabetes Study, Diabetes Care, 28, 2441, 10.2337/diacare.28.10.2441

Smith, 2005, The relationship of diet and exercise for weight control and the quality of life gap associated with diabetes, J Psychosom Res, 59, 385, 10.1016/j.jpsychores.2005.06.062

Wallberg-Henriksson, 1998, Exercise in the management of non-insulin-dependent diabetes mellitus, Sports Med, 25, 25, 10.2165/00007256-199825010-00003

Turcotte, 2008, Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise, Phys Ther, 88, 1279, 10.2522/ptj.20080018

Gulve, 2008, Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy, Phys Ther, 88, 1297, 10.2522/ptj.20080114

Fried, 2006, Chronic kidney disease and functional limitation in older people: health, aging and body composition study, J Am Geriatr Soc, 54, 750, 10.1111/j.1532-5415.2006.00727.x

Tawney, 2003, Disablement and rehabilitation in end-stage renal disease, Semin Dial, 16, 447, 10.1046/j.1525-139X.2003.16097.x

Boyce, 1997, Exercise training by individuals with predialysis renal failure: cardiorespiratory endurance, hypertension, and renal function, Am J Kidney Dis, 30, 180, 10.1016/S0272-6386(97)90051-2

Johansen, 2003, Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function, Kidney Int, 63, 291, 10.1046/j.1523-1755.2003.00704.x

Moore, 1993, Med Sci Sports Exerc, 25, 18, 10.1249/00005768-199301000-00004

McManus, 2007, Association of cystatin C with poor exercise capacity and heart rate recovery: data from the Heart and Soul Study, Am J Kidney Dis, 49, 365, 10.1053/j.ajkd.2006.12.016

Finkelstein, 2006, Association of physical activity and renal function in subjects with and without metabolic syndrome: a review of the Third National Health and Nutrition Examination Survey (NHANES III), Am J Kidney Dis, 48, 372, 10.1053/j.ajkd.2006.05.013

Lazarevic, 2007, Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients, Ren Fail, 29, 199, 10.1080/08860220601098870

Brearley, 1992, Peripheral pulse palpation: an unreliable physical sign, Ann R Coll Surg Engl, 74, 169

McDermott, 2002, The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study, Ann Intern Med, 136, 873, 10.7326/0003-4819-136-12-200206180-00008

Criqui, 1996, The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing, Vasc Med, 1, 65, 10.1177/1358863X9600100112

Hirsch, 2006, ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary—a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation, J Am Coll Cardiol, 47, 1239, 10.1016/j.jacc.2005.10.009

Greig, 1993, Treadmill walking in old age may not reproduce the real life situation, J Am Geriatr Soc, 41, 15, 10.1111/j.1532-5415.1993.tb05941.x

Gardner, 2001, Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial, J Am Geriatr Soc, 49, 755, 10.1046/j.1532-5415.2001.49152.x

Regensteiner, 1996, Exercise training improves functional status in patients with peripheral arterial disease, J Vasc Surg, 23, 104, 10.1016/S0741-5214(05)80040-0

Dawson, 1998, Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial, Circulation, 98, 678, 10.1161/01.CIR.98.7.678

Boulton, 2007, Diabetic neuropathy: classification, measurement and treatment, Curr Opin Endocrinol Diabetes Obes, 14, 141, 10.1097/MED.0b013e328014979e

Garrow, 2006, Vibration perception threshold: a valuable assessment of neural dysfunction in people with diabetes, Diabetes Metab Res Rev, 22, 411, 10.1002/dmrr.657

Boulton, 2004, Diabetic somatic neuropathies, Diabetes Care, 27, 1458, 10.2337/diacare.27.6.1458

Boulton, 2006, Treatment of prediabetic neuropathy, Curr Diab Rep, 6, 415, 10.1007/s11892-006-0072-1

Gibbons, 2006, The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy, Neurology, 66, 256, 10.1212/01.wnl.0000194314.86486.a2

1996, J Auton Nerv Syst, 58, 123, 10.1016/0165-1838(96)90001-6

Colberg, 2003, Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy, Diabetes Care, 26, 986, 10.2337/diacare.26.4.986